Software application profile: mrrobust—a tool for performing two-sample summary Mendelian randomization analyses

Abstract Motivation In recent years, Mendelian randomization analysis using summary data from genome-wide association studies has become a popular approach for investigating causal relationships in epidemiology. The mrrobust Stata package implements several of the recently developed methods. Implementation mrrobust is freely available as a Stata package. General features The package includes inverse variance weighted estimation, as well as a range of median, modal and MR-Egger estimation methods. Using mrrobust, plots can be constructed visualizing each estimate either individually or simultaneously. The package also provides statistics such as IGX2, which are useful in assessing attenuation bias in causal estimates. Availability The software is freely available from GitHub [https://raw.github.com/remlapmot/mrrobust/master/].

[1]  Ross M. Fraser,et al.  Defining the role of common variation in the genomic and biological architecture of adult human height , 2014, Nature Genetics.

[2]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[3]  Julian P. T. Higgins,et al.  HETEROGI: Stata module to quantify heterogeneity in a meta-analysis , 2005 .

[4]  N. Sheehan,et al.  A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization , 2017, Statistics in medicine.

[5]  G. Reaven,et al.  Obesity and Insulin Resistance: An Ongoing Saga , 2010, Diabetes.

[6]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[7]  G. Davey Smith,et al.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.

[8]  D. O'Gorman,et al.  Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes , 2006, Diabetologia.

[9]  Stephen Burgess,et al.  Mendelian randomization: where are we now and where are we going? , 2015, International journal of epidemiology.

[10]  Neil M Davies,et al.  The many weak instruments problem and Mendelian randomization , 2014, Statistics in medicine.

[11]  Fernando Pires Hartwig,et al.  Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.

[12]  Tanya M. Teslovich,et al.  Common variants associated with plasma triglycerides and risk for coronary artery disease , 2013, Nature Genetics.

[13]  Olena O Yavorska,et al.  MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.

[14]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[15]  N. Day,et al.  Height and glucose tolerance in adult subjects , 1991, Diabetologia.

[16]  T. Miazgowski,et al.  Are short women at risk for gestational diabetes mellitus? , 2010, European Journal of Endocrinology.

[17]  T. Nilsen,et al.  Adiposity, physical activity and risk of diabetes mellitus: prospective data from the population-based HUNT study, Norway , 2017, BMJ Open.

[18]  Ben Jann MOREMATA: Stata module (Mata) to provide various functions , 2005 .

[19]  Christopher F. Baum,et al.  IVREG2: Stata module for extended instrumental variables/2SLS and GMM estimation , 2015 .

[20]  Hashem A. Shihab,et al.  MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations , 2016, bioRxiv.

[21]  J. Eriksson,et al.  Adult height and glucose tolerance: a re‐appraisal of the importance of body mass index , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[22]  N. Sheehan,et al.  Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic , 2016, International journal of epidemiology.

[23]  G. Boden Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[24]  S. Thompson,et al.  Use of allele scores as instrumental variables for Mendelian randomization , 2013, International journal of epidemiology.

[25]  T. Erlinger,et al.  Short Stature and the Risk of Adiposity, Insulin Resistance, and Type 2 Diabetes in Middle Age , 2006, Diabetes Care.

[26]  Debbie A Lawlor,et al.  Mendelian randomization: the use of genes in instrumental variable analyses. , 2011, Health economics.

[27]  Ben Jann A Note on Adding Objects to an Existing Twoway Graph , 2015 .

[28]  A. Bella,et al.  Relationship between height, glucose intolerance, and hypertension in an urban African black adult population: a case for the "thrifty phenotype" hypothesis? , 2000, Journal of the National Medical Association.

[29]  David M. Evans,et al.  Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. , 2015, Annual review of genomics and human genetics.

[30]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[31]  Dylan S. Small,et al.  A review of instrumental variable estimators for Mendelian randomization , 2015, Statistical methods in medical research.

[32]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.